Graft-versus-host disease prophylaxis: does drug dosage matter?
Department of Hematology Transplantation, Hospital Saint Louis, Paris, France. gerard.socie@sls.aphp.fr
Gérard
G
Socié
D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000097:blood*; D005260:Female; D006086:Graft vs Host Disease / Q000097:blood*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood*; D008297:Male; D016559:Tacrolimus / Q000097:blood*
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus